Get Real-Time Lab Insights to Speed Clinical Trials
Executive Brief
- The News: LabConnect and OmniScience collaborate on AI Agentic solution
- Clinical Win: Vivo platform unifies disparate data sources for real-time insights
- Target Specialty: Clinical trial sponsors and data science teams
Key Data at a Glance
Company: LabConnect
Collaboration Partner: OmniScience
AI Platform: Vivo
Specialized Implementation: Vivo-Lab
Goal: Accelerate trial timelines and improve outcomes
Mission: Transform lab data into real-time actionable intelligence
Get Real-Time Lab Insights to Speed Clinical Trials
What You Should Know:
– LabConnect, a global provider of central laboratory services, has announced a strategic collaboration with OmniScience, the AI company behind the Vivo platform.
– Together, the companies will deliver an AI Agentic solution to give sponsors intelligent, real-time insights from clinical trial lab data.
Transforming Lab Data into Real-Time Action
Clinical trial lab data is often complex, siloed, and delayed, which can lead to slow decision-making and increased risk. By combining LabConnect’s expertise in central lab testing with OmniScience’s Vivo platform, trial sponsors can now unify fragmented lab datasets, automate oversight, and surface risk signals. This collaboration aims to accelerate trial timelines and improve outcomes.
Vivo is an AI-native clinical trial intelligence platform that unifies disparate data sources to provide real-time insights. The platform functions as a “control tower” to equip clinical, operational, safety, and data science teams with the clarity they need to act faster and more confidently.
Vivo-Lab, a specialized implementation of Vivo, brings this same intelligence to laboratory data. It streamlines lab workflows by surfacing critical trends, anomalies, and site-level discrepancies as they happen, helping teams move from reactive to proactive oversight.
“Our mission at OmniScience is to help trial teams see and act faster,” said Angela Holmes, CEO and Co-Founder of OmniScience. “Partnering with LabConnect extends that vision by transforming lab data into real time actionable intelligence that sponsors can trust”.
Clinical Perspective — Dr. Ishita Bhatt, Pathology
Workflow: With the introduction of Vivo-Lab, I expect to see a significant change in my daily routine, as it streamlines lab workflows by surfacing critical trends and anomalies in real-time. This will enable me to move from reactive to proactive oversight, allowing for faster decision-making. By automating lab data oversight, I'll be able to focus on higher-level tasks.
Economics: The article doesn't address cost directly, but the potential to accelerate trial timelines and improve outcomes could lead to significant cost savings. By reducing the time and resources required for clinical trials, sponsors may be able to allocate funds more efficiently. However, the exact economic impact of this collaboration is unclear.
Patient Outcomes: The collaboration between LabConnect and OmniScience aims to improve patient outcomes by providing trial sponsors with real-time insights from clinical trial lab data. While the article doesn't cite specific patient outcome data, the ability to surface risk signals and automate oversight could lead to better trial management and ultimately, improved patient care. By equipping clinical teams with the clarity they need to act faster, we're likely to see more effective trial management.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact [email protected].